In addition to Angelman syndrome, whole-exome sequencing and CNV analyses identified a compound heterozygous variant in the GALC gene; moreover, a significant decrease was observed in galactose cerebrosidase activity. This evidence concerns the gene GALC and Angelman syndrome.